First there were Victoza and Saxenda, then Ozempic seized the spotlight - followed by Wegovy and Mounjaro. And ever-better ...

A new study warns that GLP-1 weight-loss drugs like Ozempic and Wegovy may cause false cancer signals on PET-CT scans, ...

Biohacker Bryan Johnson has revealed he 'microdosed' weight-loss medications, despite having under 10 percent body fat. The ...

Scientists discovered that Gila monster venom contains a compound that slows digestion. It led to one of the biggest medical ...

Mumbai: Global pharma major Lupin Limited has announced the launch of Liraglutide Injection, 18 mg/3 mL (6 mg/mL) ...

Global pharma major Lupin Limited (Lupin) announced the launch of liraglutide injection, 18 mg/3 mL (6 mg/mL) single-patient-use prefilled pen, in the United States. Liraglutide injection, 18 mg/3 mL ...

Lupin has announced the launch of its Liraglutide Injection, 18 mg/3 mL (6 mg/mL) Single-Patient-Use Prefilled Pen in the United States.

Lupin share price fell 1 percent in the opening trade on October 6 following the company received four observations to its ...

Stories like Mendosa’s have become commonplace in the age of Ozempic. According to a 2024 Kaiser Family Foundation survey, ...

Mumbai-based pharma major Lupin has launched Liraglutide Injection in US to help adults and children with type 2 diabetes ...

Lupin launches Liraglutide Injection, a generic diabetes medication, in the US market. Aims to improve glycemic control.

The product is bioequivalent to Novo Nordisk Inc's Victoza injection. It is indicated as an adjunct to diet and exercise to ...